{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/668c679f2387098e04839cc3?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Tuesday, July 9, 2024","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1720477555593-7ca536812e30ced17ec8d8a1fe1c940b.jpeg?height=200","description":"<p>In two separate rulings, federal judges partially block both the FTC’s noncompete ban and a federal gender nondiscrimination rule.&nbsp;Massachusetts lawmakers target real estate investment trusts in a sweeping healthcare bill.&nbsp;And the FDA approves Eli Lilly’s early Alzheimer’s treatment.&nbsp;That’s coming up on today’s episode of Gist Healthcare Daily.&nbsp;</p>","author_name":"Gist Healthcare Daily"}